Cresset Asset Management, LLC Amgen Inc Transaction History

Cresset Asset Management, LLC

$20.6 Billion
Q1 2024

A detailed history of Cresset Asset Management, LLC transactions in Amgen Inc stock. As of the latest transaction made, Cresset Asset Management, LLC holds 69,480 shares of AMGN stock, worth $23.3 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares

69,480

Previous 67,403 3.08%

Holding current value

$23.3 Million

Previous $19.4 Million 1.76%

% of portfolio

0.1%

Previous 0.12%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$268.87 - $324.56 $558,442 - $674,111	2,077 Added 3.08%	69,480 $19.8 Million
Q4 2023 Feb 14, 2024	SELL	$255.7 - $288.46 $35,030 - $39,519	-137 Reduced 0.2%	67,403 $19.4 Million
Q3 2023 Nov 14, 2023	BUY	$218.65 - $271.46 $889,249 - $1.1 Million	4,067 Added 6.41%	67,540 $18.2 Million
Q2 2023 Aug 14, 2023	BUY	$214.27 - $253.37 $11 Million - $13 Million	51,313 Added 421.98%	63,473 $14.1 Million
Q1 2023 May 12, 2023	SELL	$225.79 - $275.2 $424,259 - $517,100	-1,879 Reduced 13.38%	12,160 $2.94 Million

Q4 2022 Feb 14, 2023	SELL	$229.03 - $291.01 $115,202 - $146,378	-503 Reduced 3.46%	14,039 $3.69 Million
Q3 2022 Nov 14, 2022	SELL	$224.46 - $253.15 $510,422 - $575,663	-2,274 Reduced 13.52%	14,542 $3.28 Million
Q2 2022 Aug 15, 2022	SELL	$230.71 - $256.74 $727,659 - $809,757	-3,154 Reduced 15.79%	16,816 $4.07 Million
Q1 2022 May 16, 2022	SELL	$219.27 - $242.57 $721,836 - $798,540	-3,292 Reduced 14.15%	19,970 $4.83 Million
Q4 2021 Feb 10, 2022	SELL	$198.88 - $227.6 $1.66 Million - $1.9 Million	-8,349 Reduced 26.41%	23,262 $5.23 Million
Q3 2021 Nov 15, 2021	BUY	$212.27 - $248.7 $682,660 - $799,819	3,216 Added 11.33%	31,611 $6.72 Million
Q2 2021 Aug 10, 2021	SELL	$233.58 - $259.14 $32,234 - $35,761	-138 Reduced 0.48%	28,395 $6.92 Million
Q1 2021 May 12, 2021	BUY	$221.91 - $258.6 $249,426 - $290,666	1,124 Added 4.1%	28,533 $7.1 Million
Q4 2020 Feb 11, 2021	SELL	$216.38 - $257.67 $1.83 Million - $2.18 Million	-8,445 Reduced 23.55%	27,409 $6.3 Million
Q3 2020 Nov 13, 2020	SELL	$234.65 - $260.95 $312,788 - $347,846	-1,333 Reduced 3.58%	35,854 $9.11 Million
Q2 2020 Aug 04, 2020	SELL	$197.81 - $242.74 $86,838 - $106,562	-439 Reduced 1.17%	37,187 $8.77 Million
Q1 2020 May 15, 2020	SELL	$182.24 - $241.7 $727,684 - $965,108	-3,993 Reduced 9.59%	37,626 $7.63 Million
Q4 2019 Feb 10, 2020	SELL	$189.21 - $243.2 $1.12 Million - $1.44 Million	-5,921 Reduced 12.45%	41,619 $10 Million
Q3 2019 Nov 13, 2019	BUY	$174.11 - $208.62 $5.97 Million - $7.15 Million	34,270 Added 258.25%	47,540 $9.2 Million
Q2 2019 Aug 12, 2019	SELL	$166.7 - $195.41 $7.47 Million - $8.76 Million	-44,810 Reduced 77.15%	13,270 $2.45 Million
Q1 2019 May 15, 2019	BUY	$180.87 - $203.88 $9.8 Million - $11 Million	54,174 Added 1386.94%	58,080 $2.41 Million
Q4 2018 May 21, 2019	BUY	$178.4 - $208.25 $696,830 - $813,424	3,906 New	3,906 $760,000

Others Institutions Holding AMGN

# of Institutions

2,969

Shares Held

402M

Call Options Held

6.59M

Put Options Held

6.61M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $180B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cresset Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cresset Asset Management, LLC with notifications on news.

Account

Cresset Asset Management, LLC Amgen Inc Transaction History